Related Experiment Video
Updated: Jun 17, 2025
12:03
Generation of Human Induced Pluripotent Stem Cells from Peripheral Blood Using the STEMCCA Lentiviral Vector
Published on: October 31, 2012
26.6K
Generation of Induced Pluripotent Stem Cells from Erythroid Progenitor Cells
Zeynep Busra Aksoy1, Kamil Can Akcali2,3
1Ankara University, Stem Cell Institute, Ankara, Turkey.
Methods in Molecular Biology (Clifton, N.J.)
|August 6, 2024
Summary
This study details generating induced pluripotent stem cells (iPSCs) from erythroid progenitor cells (EPCs) via reprogramming. This method enhances efficiency and reduces costs for valuable iPSC applications in research and therapy.
Area of Science:
- Stem Cell Biology
- Cellular Reprogramming
- Regenerative Medicine
Background:
- Induced pluripotent stem cells (iPSCs) closely mimic embryonic stem cells (ESCs).
- iPSCs can be generated from various somatic cells, including peripheral blood mononuclear cells (PBMCs).
- PBMCs are preferred for human iPSC generation due to non-invasive isolation.
Purpose of the Study:
- To outline a general framework for inducing iPSCs from erythroid progenitor cells (EPCs).
- To detail pluripotency confirmation and cultivation methods for downstream applications.
- To enhance efficiency and reduce costs in iPSC generation.
Main Methods:
- Reprogramming somatic cells, specifically EPCs derived from PBMCs, to an embryonic-like state.
- Utilizing EPC enrichment to increase the percentage of reprogrammable cells.
- Confirming pluripotency and cultivating induced iPSCs.
Main Results:
- Successfully generated induced pluripotent stem cells (iPSCs) from erythroid progenitor cells (EPCs).
- EPC enrichment improved reprogramming efficiency and reduced costs.
- Established a framework for iPSC generation, confirmation, and cultivation.
Conclusions:
- Induced pluripotent stem cells (iPSCs) derived from EPCs offer a cost-effective and efficient source for stem cell research.
- This protocol provides a valuable resource for in vitro research, cell therapy, drug discovery, and tissue engineering.
- The method highlights the potential of PBMCs as a source for generating clinical-grade iPSCs.
Related Concept Videos
01:13Induced Pluripotent Stem Cells
22.1K
Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore...
22.1K
01:22iPS Cell Differentiation
2.7K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
2.7K
00:58Embryonic Stem Cells
26.7K
Embryonic stem (ES) cells are undifferentiated pluripotent cells, meaning they can produce any cell type in the body. This gives them tremendous potential in science and medicine since they can generate specific cell types for use in research or to replace body cells lost due to damage or disease.
26.7K